Pompe Disease Market Size And Share

  • Report Code : TIPRE00015809
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Principales conclusions et analyse des parts de marché de la maladie de Pompe d'ici 2025-2031

Buy Now

Pompe Disease Market Report Pompe Disease Market Scope and Analysis Pompe Disease Market Size and Share

Pompe Disease Market Report Analysis

Pompe Disease Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Amicus Therapeutics
  • BioMarin Pharmaceutical
  • Genzyme
  • Audentes Therapeutics
  • EpiVax
  • Oxyrane
  • Sangamo BioSciences
  • Valerion Therapeutics
  • Centogene

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Type de thérapie
  • thérapie de remplacement enzymatique
  • thérapie de réduction de substrat
By Type de molécule
  • produits biologiques
  • petites molécules
By Voie d'administration
  • orale
  • parentérale
By Formes posologiques
  • solides
  • liquides